ChemicalBook >> CAS DataBase List >>Rozanolixizumab

Rozanolixizumab

CAS No.
1584645-37-3
Chemical Name:
Rozanolixizumab
Synonyms
UCB7665;UCB-7665;Rozanolixizumab;Rozanolixizumab (anti-FCGRT);Research Grade Rozanolixizumab;Research Grade Rozanolixizumab(DHF14602)
CBNumber:
CB28080992
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-07-27 17:00:41

Rozanolixizumab Properties

storage temp. Store at -20°C
form Liquid
color Colorless to light yellow
FDA UNII P7186074QC

Rozanolixizumab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0182841 Rozanolixizumab 99.34% 1584645-37-3 1mg $379 2026-06-04 Buy
ChemScene CS-0182841 Rozanolixizumab 99.34% 1584645-37-3 5mg $812 2026-06-04 Buy
ChemScene CS-0182841 Rozanolixizumab 99.34% 1584645-37-3 10mg $1300 2026-06-04 Buy
aablocks AA029J4M Rozanolixizumab ≥95%(SDS-PAGE&SEC-HPLC) 1584645-37-3 1mg $1140 2026-06-02 Buy
aablocks AA029J4M Rozanolixizumab ≥95%(SDS-PAGE&SEC-HPLC) 1584645-37-3 5mg $2566 2026-06-02 Buy
Product number Packaging Price Buy
CS-0182841 1mg $379 Buy
CS-0182841 5mg $812 Buy
CS-0182841 10mg $1300 Buy
AA029J4M 1mg $1140 Buy
AA029J4M 5mg $2566 Buy

Rozanolixizumab Chemical Properties, Uses, Production

Uses

Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].

in vivo

Intravenous (IV) rozanolixizumab dosing in cynomolgus monkeys demonstrated non-linear pharmacokinetics indicative of target-mediated drug disposition; single IV rozanolixizumab doses (30 mg/kg) in cynomolgus monkeys reduced plasma IgG concentration by 69% by Day 7 post-administration. Daily IV administration of rozanolixizumab (initial 30 mg/kg loading dose; 5 mg/kg daily thereafter) reduced plasma IgG concentrations in all cynomolgus monkeys, with low concentrations maintained throughout the treatment period (42 days)[1].

References

[1] Smith B, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10(7):1111-1130. DOI:10.1080/19420862.2018.1505464

Rozanolixizumab Preparation Products And Raw materials

Raw materials

Preparation Products

Rozanolixizumab Suppliers

Global Suppliers ( 27)
Supplier Tel Email Country ProdList Advantage
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 981810490@qq.com China 1577 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
TargetMol Chemicals Inc. 4008200310 15002144251 marketing@tsbiochem.com China 24951 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7283 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581 sales@chemhifuture.com China 5985 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58

View Latest Price from Rozanolixizumab manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Rozanolixizumab pictures 2026-07-27 Rozanolixizumab
1584645-37-3
$228.00-795.00 97.2% (SDS-PAGE); 95.9% (SEC-HPLC) 10g TargetMol Chemicals Inc.
Rozanolixizumab pictures 2026-07-13 Rozanolixizumab
1584645-37-3
1g 98 1000g Shaanxi Dideu New Materials Co. Ltd
  • Rozanolixizumab pictures
  • Rozanolixizumab
    1584645-37-3
  • $228.00-795.00
  • 97.2% (SDS-PAGE); 95.9% (SEC-HPLC)
  • TargetMol Chemicals Inc.
Rozanolixizumab Research Grade Rozanolixizumab(DHF14602) UCB7665 UCB-7665 Research Grade Rozanolixizumab Rozanolixizumab (anti-FCGRT) 1584645-37-3